BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 31359335)

  • 1. Emerging roles of aerobic glycolysis in breast cancer.
    Wu Z; Wu J; Zhao Q; Fu S; Jin J
    Clin Transl Oncol; 2020 May; 22(5):631-646. PubMed ID: 31359335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The determinants of metabolic discrepancies in aerobic glycolysis: Providing potential targets for breast cancer treatment.
    Littleflower AB; Parambil ST; Antony GR; Subhadradevi L
    Biochimie; 2024 May; 220():107-121. PubMed ID: 38184121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
    Parajuli P; Tiwari RV; Sylvester PW
    Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of glycolysis and the Warburg effect by estrogen-related receptors.
    Cai Q; Lin T; Kamarajugadda S; Lu J
    Oncogene; 2013 Apr; 32(16):2079-86. PubMed ID: 22665055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
    Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
    PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.
    Feng J; Li J; Wu L; Yu Q; Ji J; Wu J; Dai W; Guo C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):126. PubMed ID: 32631382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action.
    Zhan L; Su F; Li Q; Wen Y; Wei F; He Z; Chen X; Yin X; Wang J; Cai Y; Gong Y; Chen Y; Ma X; Zeng J
    Front Pharmacol; 2023; 14():1257450. PubMed ID: 37693915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis.
    Arundhathi JRD; Mathur SR; Gogia A; Deo SVS; Mohapatra P; Prasad CP
    Mol Biol Rep; 2021 May; 48(5):4733-4745. PubMed ID: 34047880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K.
    Courtnay R; Ngo DC; Malik N; Ververis K; Tortorella SM; Karagiannis TC
    Mol Biol Rep; 2015 Apr; 42(4):841-51. PubMed ID: 25689954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive role of SIK1 and SIK3 isoforms in aerobic glycolysis and cell growth of breast cancer through the regulation of p53 and mTOR signaling pathways.
    Ponnusamy L; Manoharan R
    Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(5):118975. PubMed ID: 33545220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
    Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells.
    Zancan P; Sola-Penna M; Furtado CM; Da Silva D
    Mol Genet Metab; 2010 Aug; 100(4):372-8. PubMed ID: 20483646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress on the mechanism of glycolysis in ovarian cancer.
    Li C; Liu FY; Shen Y; Tian Y; Han FJ
    Front Immunol; 2023; 14():1284853. PubMed ID: 38090580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleanolic Acid Inhibits High Salt-Induced Exaggeration of Warburg-like Metabolism in Breast Cancer Cells.
    Amara S; Zheng M; Tiriveedhi V
    Cell Biochem Biophys; 2016 Sep; 74(3):427-34. PubMed ID: 27236294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-Tocotrienol Suppression of the Warburg Effect Is Mediated by AMPK Activation in Human Breast Cancer Cells.
    Dronamraju V; Ibrahim BA; Briski KP; Sylvester PW
    Nutr Cancer; 2019; 71(7):1214-1228. PubMed ID: 30955359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.
    Rivera Rivera A; Castillo-Pichardo L; Gerena Y; Dharmawardhane S
    PLoS One; 2016; 11(6):e0157251. PubMed ID: 27285995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.